Dec 18 (Reuters) - Novo Holdings, the controlling shareholder of Novo Nordisk (NOVOb.CO), opens new tab, on Wednesday sealed its $16.5 billion deal for Catalent (CTLT.N), opens new tab ...
SOMERSET, N.J. & COPENHAGEN, Denmark--(BUSINESS WIRE)--Catalent, Inc. (“Catalent”), a leader in enabling the development and supply of better treatments for patients worldwide, and Novo ...
Dec 14 (Reuters) - All regulatory closing conditions related to Novo Holdings' $16.5 billion acquisition of U.S. contract drug maker Catalent (CTLT.N), opens new tab had been fulfilled ...
Catalent says it worked on more than half of the new drugs approved by the FDA over the past 10 years. On Monday, Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) announced plans to invest ...
New food hygiene ratings have been awarded to 31 of West Lothian’s establishments, the Food Standards Agency’s website shows.
Catalent to Strengthen its Leading Position as a Global Service Provider for the Pharma and Biotech Industry under Private Ownership SOMERSET, N.J. & COPENHAGEN, Denmark, December 18, 2024 ...